Yongsub Kim

Associate Professor

University of Ulsan College of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Cancer Biology Cancer Biology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yongsub Kim is an Associate Professor at the University of Ulsan College of Medicine in South Korea. His research focuses on advanced gene editing techniques, including CRISPR-based methods for oncogenic mutation correction and therapeutic applications. Recent publications explore inflammatory bone erosion, gene editing for genetic disorders, and mechanisms of cancer cell behavior. His work aims to identify novel therapeutic targets and improve strategies for treating various cancers.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Jong-Il Kim

Seoul National University

SOUTH KOREA

View details

Eun-Jin Lee

National Institute of Standards and Technology

UNITED STATES

View details

Daesik Kim

Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Hye-Yeon Hwang

Sungkyunkwan University

SOUTH KOREA

View details

Suhwan Chang

University of Ulsan College of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yongsub Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Dysfunction in parkin aggravates inflammatory bone erosion by reinforcing osteoclast activity.

Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing.

Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery.

Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers.

Functional Analysis of Variants in BRCA1 Using CRISPR Base Editors.

CRISPR prime editing for unconstrained correction of oncogenic KRAS variants.

Targeted genomic translocations and inversions generated using a paired prime editing strategy.

Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis.

Engineered prime editors with PAM flexibility

AWP1 Restrains the Aggressive Behavior of Breast Cancer Cells Induced by TNF-α.

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors.

Collaborators (5)

Jong-Il Kim

Eun-Jin Lee

Daesik Kim

Hye-Yeon Hwang

Suhwan Chang

Make your next move.